Executive Intelligence

Prashant Warier

Founder

Prashant Warier is listed as a founder of Qure.ai based in India on Brel Digital’s verified company intelligence record.

Company Intelligence Official Website
In this profile

Quick Facts

  • Role Founder
  • Company Qure.ai
  • Country India
  • Industry AI in Healthcare
  • Founded 2016
  • Known For Qure.ai is among the most regulatorily validated radiology AI vendors globally, with 26 FDA-cleared indications across…
  • Status Active
  • Last Reviewed Jul 2026

Executive Summary

Prashant Warier appears in Brel Digital’s verified company_founders attribution for Qure.ai based in India in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted. Company context (from the verified Qure.ai profile): Mumbai medical imaging AI company with broad FDA-cleared portfolio spanning chest X-ray, brain CT, and lung nodule quantification Why the company matters (verified company field): Qure.ai is among the most regulatorily validated radiology AI vendors globally, with 26 FDA-cleared indications across nine products as of February 2026 — a useful benchmark for hospitals comparing CADe triage tools on chest radiography volume. Official company website on file: https://www.qure.ai. Readers should consult that site and the Sources section for primary evidence. Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Career Timeline

Verified company milestones linked to this executive’s organization.

  1. 2016 Company founded

    Qure.ai was founded in 2016 per the company profile source on file.

    Source
  2. 2016 Development

    2016: Qure.ai founded in Mumbai; Prashant Warier serves as founder and chief executive officer.

    Source
  3. 2020 Product

    2020: FDA clearance described by Qure.ai as most comprehensive for its brain CT product at that time.

    Source
  4. 2026 Product

    February 26, 2026: FDA 510(k) clearance of qXR-Detect with six new chest X-ray indications, bringing total FDA-cleared indications to 26 across nine products.

    Source

Connected Company

Connected Products

Connected Reports

Connected Insights

Industry Intelligence

AI in Healthcare Open industry

Prashant Warier appears in Brel Digital’s verified company_founders attribution for Qure.ai based in India in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.

Company context (from the verified Qure.ai profile): Mumbai medical imaging AI company with broad FDA-cleared portfolio spanning chest X-ray, brain CT, and lung nodule quantification

Why the company matters (verified company field): Qure.ai is among the most regulatorily validated radiology AI vendors globally, with 26 FDA-cleared indications across nine products as of February 2026 — a useful benchmark for hospitals comparing CADe triage tools on chest radiography volume.

Official company website on file: https://www.qure.ai. Readers should consult that site and the Sources section for primary evidence.

Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Request a correction if you represent this company or believe information is inaccurate.

The AI Brief

Founder and company intelligence, weekly.

Subscribe